Naunyn Schmiedebergs Arch Pharmacol 1999, 359:310–321 CrossRefPub

Naunyn Schmiedebergs Arch Pharmacol 1999, 359:310–321.CrossRefPubMed 13. Haller CA, Benowitz NL, Jacob P: Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med 2005, 118:998–1003.CrossRefPubMed

14. Andersen T, Fogh J: Weight loss and delayed gastric emptying following a South American herbal BMN 673 in vitro preparation in overweight patients. J Hum Nutr Diet 2001, 14:243–250.CrossRefPubMed 15. Barwell CJ, Basma AN, Lafi MA, Leake LD: Deamination of hordenine by monoamine oxidase and its action on vasa deferentia of the rat. J Pharm Pharmacol 1989, 41:421–423.PubMed 16. Galitzky J, Taouis M, Berlan M, Riviere D, Garrigues M, Lafontan M: Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest 1988, 18:587–594.CrossRefPubMed 17. Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F, Gal J, Shih JC: Increased stress response and β-phenylethylamine in MAOB-deficient mice. Nat Genetics 1997, 17:206–210.CrossRef 18. Sabelli H, Fink P, Fawcett J, Tom C: Sustained selleck compound antidepressant effect of PEA replacement. J

Neuropsychiatry Clin Neurosci 1996, 8:168–171.PubMed 19. Sabelli H, Borison RL, Diamond BI, Havdala HS, Narasimhachari N: Phenylethylamine and brain function. Biochem Pharmacol 1978, 27:1707–1711.CrossRefPubMed 20. McNair DM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego, CA: Educational and Industrial Testing Service 1971. 21. Greenway FL, de Jonge L, Blanchard

D, Frisard M, Smith SR: Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes Res 2004, 12:1152–1157.CrossRefPubMed 22. Slezak T, Francis PS, Anastos N, Barnett NW: Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection. Analy Chem Acta 2007, 593:98–102.CrossRef 23. Sunitinib ic50 Frank M, Weckman TJ, Wood T, Woods WE, Tai CL, Chang SL, Ewing A, Blake JW, Tobin T: Hordenine: pharmacology, pharmacokinetics and behavioral effects in the horse. Equine Vet J 1990, 22:437–441.CrossRefPubMed 24. Vukovich MD, Schoorman R, Heilman C, Jacob P 3rd, Benowitz NL: Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clin Exp Pharmacol Physiol 2005, 32:47–53.CrossRefPubMed 25. Brown CM, McGrath JC, Midgley JM, Muir AG, O’Brien JW, Thonoor CM, Williams CM, Wilson VG: Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. Br J Pharmacol 1988, 93:417–429.PubMed 26. Lafontan M, Berlan M, Galitzky J, Montastruc JL: Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies. Am J Clin Nutr 1992,55(1 Suppl):219S-227S.PubMed 27.

Comments are closed.